CHINA PHARMA HOLDINGS, INC. Allowance for Doubtful Other Receivables, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Allowance for Doubtful Other Receivables, Current of $27.98 thousand as of 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Notes › Receivables › and Others
us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent · last filed 2021-05-14
- 2021-03-31: Allowance for Doubtful Other Receivables, Current $27.98K.
- 2020-12-31: Allowance for Doubtful Other Receivables, Current $22.32K; Allowance for Doubtful Other Receivables, Current as first filed $27.29K.
- 2020-09-30: Allowance for Doubtful Other Receivables, Current $27.32K.
- 2020-06-30: Allowance for Doubtful Other Receivables, Current $23.71K.
| Period end | Allowance for Doubtful Other Receivables, Current | Allowance for Doubtful Other Receivables, Current as first filed |
|---|---|---|
| 2021-03-31 | $27.98K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $22.32K 10-Q · filed 2021-05-14 | $27.29K 10-K · filed 2021-03-26 |
| 2020-09-30 | $27.32K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $23.71K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $22.32K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $22.73K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $46.64K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $40.55K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $7.19K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $34.88K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $39.32K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $40.07K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $43.93K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $40.01K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $55.80K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $60.63K 10-Q · filed 2017-08-14 | |
| 2016-12-31 | $71.55K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |